Ykrita Life Sciences
Bengaluru · Founded 2020
About Ykrita Life Sciences
YLS is developing a bio-medical device: Bio-engineered Artificial Ectopic Liver (BAEL), aimed at helping clinicians to treat patients suffering from liver failure while eliminating the need for an organ transplant, hospitalization, and exorbitant expenditure on the treatment.
Company Facts
- Founded: 2020
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $1.2M
- Funding stage: Seed
- Last round: Seed (Nov 2021)
- Website: https://ykrita.com
- Phone: +91 080-29900665
Industries & Categories
Health Care, Life Science, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/ykrita-life-sciences-194881 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.